Schwab US Dividend Equity ETF Reverses In December: What's Going On?

Benzinga04:53

Bristol Myers Squibb's Sotyktu Shows Results in Psoriatic Arthritis Trials

BenzingaDec 23 20:00

Express News | Bristol-Myers Squibb Co: Sotyktu Was Well-Tolerated and Demonstrated Safety Consistent With Established Profile

BreakingsDec 23 19:59

Express News | Bristol-Myers Squibb Co - Phase 3 Trials Met Primary Endpoint With Significant Acr20 Response

BreakingsDec 23 19:59

Express News | Bristol Myers Squibb Announces Positive Topline Results From Two Pivotal Phase 3 Trials Evaluating Sotyktu (Deucravacitinib) in Adults With Psoriatic Arthritis

BreakingsDec 23 19:59

Bristol Myers Squibb Wins EU Approval for New Colorectal Cancer Treatment

BenzingaDec 23 19:46